SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-048385
Filing Date
2024-04-25
Accepted
2024-04-25 16:30:53
Documents
5
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A dsgn-def14a-2024.htm DEF 14A 728991
2 GRAPHIC img131554365_0.jpg GRAPHIC 139229
3 GRAPHIC img131554365_1.jpg GRAPHIC 139229
4 GRAPHIC img131554365_2.jpg GRAPHIC 190684
5 GRAPHIC img131554365_3.jpg GRAPHIC 72210
  Complete submission text file 0000950170-24-048385.txt   1464849
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40288 | Film No.: 24876874
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)